Dr. Gennady Rubinstein, MD

Dr. Rubinstein practices at Golden State Dermatopathology in Walnut Creek, California.

Dr. Rubinstein's NPI, 1720083744, was assigned on June 16, 2005. Dr. Rubinstein graduated from Boston University School Of Medicine in 1999. Dr. Rubinstein holds California license A74924.

Dr. Rubinstein's primary practice is Golden State Dermatopathology, at 370 N Wiget Ln, Ste 250, Walnut Creek, CA 94598. The practice phone is (925) 278-7592.

Dr. Rubinstein's primary practice is Golden State Dermatopathology in Walnut Creek, California. The medical group on file is Golden State Dermatology. Dmand AI also links Dr. Rubinstein to 2 more group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account. Dr. Rubinstein's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubinstein practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rubinstein's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rubinstein is board certified in dermatology by the American Board of Dermatology. Dr. Rubinstein is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Rubinstein treats.

CMS data shows 7,233 Medicare services from Dr. Rubinstein across 26 procedure codes in 2024, for 1,331 Medicare patients. Medicare paid $539,219 for them. Every service was in an office.

CMS counts 1,331 Medicare patients who saw Dr. Rubinstein in 2024. The largest group is 65 to 74, with 613 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rubinstein's median patient age at 61, with 53% women.

In 2024, Dr. Rubinstein wrote 4,887 Medicare Part D claims for 900 patients. 87% of them were for generic drugs. CMS names the drug for 4,729 of them, across 49 drugs with 11 or more claims each, at $2,429,416 in total drug cost. In 2023, CMS named 5,020 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rubinstein for performance year 2024, reported individually. Dr. Rubinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,631 procedures of removal of skin lesions by Dr. Rubinstein, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Rubinstein, published from 2019 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Microscopy, Confocal.

CMS Open Payments shows 1,718 general payments to Dr. Rubinstein from 47 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Galderma Laboratories, L.P. paid the most, $110,897.

Dmand AI lists 2 awards for Dr. Rubinstein.

Dr. Rubinstein graduated from Boston University School Of Medicine in 1999. Dr. Rubinstein is a member of AAD and ASDS.

Dr. Rubinstein is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.